Clinical trial
Tyrosine Kinase Inhibitors in DyplAsia of Lung Epithelium
NCT01405846 is registered in ClinicalTrials.gov with Papworth Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tyrosine Kinase Inhibitors in DyplAsia of Lung Epithelium
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 31, 2011
- Completion date
- June 30, 2016
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer, lung cancer